Business
TerrAscend Appoints Jason Marks As New Chief Legal Officer and Announces Other Management Changes
TerrAscend Appoints Jason Marks As New Chief Legal Officer and Announces Other Management ...
About this update from Terrascend Corp.
[{"type":"text","content":"\n\n\n\nTerrAscend Appoints Jason Marks As New Chief Legal Officer and Announces Other Management Changes\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nNEW YORK and TORONTO, Aug. 5, 2020\n\n\n\nNEW YORK and TORONTO, Aug. 5, 2020 /CNW/ - TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) (\"TerrAscend\" or the \"Company\"), a leading North American cannabis operator, today announced the appointment of Jason Marks as Chief Legal Officer. Mr. Marks brings to TerrAscend more than two decades of legal experience and over a decade of global experience. He has served in a variety of functions for multi-national companies in life sciences, including biotechnology, pharmaceuticals, consumer health, and medical devices.\n\"We're committed to prudently scaling our organization as we execute on the opportunity ahead and drive sustainable business growth,\" said Jason Ackerman, Chief Executive Officer and Chairman of TerrAscend. \"With a breadth of experience in the life sciences industry, we're thrilled to have Jason join us and bring a unique perspective to our executive team.\" \nMost recently, Mr. Marks served as the Chief Legal Officer, General Counsel & Corporate Secretary of InflaRx N.V., a publicly traded biotechnology company. In this role, he was a member of the executive management team responsible for all aspects of legal, compliance, and corporate governance, as well as driving key business and strategic initiatives. Mr. Marks was also responsible for the operations of the company's U.S. subsidiary. \nPrior to his role at InflaRx, Mr. Marks was SVP, Head of Legal Branded Rx (Salix) and Global Litigation & Government Investigations, at Bausch Health, where he managed some of the highest-profile matters in life sciences, was the lead lawyer for Salix, a $2B division of Bausch Health, and created and led the company's first Legal Operations and Enterprise Risk Management functions. Mr. Marks also held senior roles at Novartis's Alcon division, including the head of legal for North America and at Stryker Corporation. Mr. Marks received a J.D. from The Ge...